Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
6 hedge funds and large institutions have $1.46M invested in Lucira Health, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 25 closing their positions.
41% more capital invested
Capital invested by funds: $1.04M → $1.46M (+$422K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
79% less funds holding
Funds holding: 29 → 6 (-23)
92% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$26.2K |
| 2 |
Barclays
London,
United Kingdom
|
+$1.03K |
| 3 |
CS
Clear Street
New York
|
+$356 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$80.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$69.3K |
| 3 |
Citigroup
New York
|
-$48.5K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$30.1K |
| 5 |
Morgan Stanley
New York
|
-$23.1K |
LHDX Hedge Fund Activity: Q1 2023 in Review
6 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q1 2023, worth a combined $1.46M — up 41% from $1.04M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of LHDX and 2 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Simplex Trading, adding an estimated $26.2K. The largest seller was EPIQ Capital Group, exiting entirely with an estimated $80.5K sold.
- 6 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q1 2023, down from 29 in Q4 2022.
- Funds reported $1.46M of Lucira Health, Inc. Common Stock stock for Q1 2023, up 41% quarter-over-quarter.
- 2 funds opened new Lucira Health, Inc. Common Stock positions in Q1 2023 and 25 closed out, a net change of -23 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q1 2023 was Simplex Trading, an estimated $26.2K added.
- The largest Lucira Health, Inc. Common Stock seller in Q1 2023 was EPIQ Capital Group, an estimated $80.5K sold.
Based on aggregated 13F filings for Q1 2023.